{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T11:36:44Z","timestamp":1771069004066,"version":"3.50.1"},"reference-count":44,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2007,8,1]],"date-time":"2007-08-01T00:00:00Z","timestamp":1185926400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,10,7]],"date-time":"2016-10-07T00:00:00Z","timestamp":1475798400000},"content-version":"vor","delay-in-days":3355,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2007,8]]},"DOI":"10.1038\/sj.mt.6300201","type":"journal-article","created":{"date-parts":[[2007,5,23]],"date-time":"2007-05-23T15:13:27Z","timestamp":1179933207000},"page":"1423-1431","source":"Crossref","is-referenced-by-count":72,"title":["Correction of Clinical Manifestations of Canine Mucopolysaccharidosis I with Neonatal Retroviral Vector Gene Therapy"],"prefix":"10.1016","volume":"15","author":[{"given":"Anne M","family":"Traas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiucui","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mindy","family":"Tittiger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Schaller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia","family":"O'donnell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meg M","family":"Sleeper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles","family":"Vite","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ramin","family":"Herati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gustavo D","family":"Aguirre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Haskins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katherine P","family":"Ponder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1038\/sj.mt.6300201_bib1","series-title":"Metabolic and Molecular Basis of Inherited Disease","first-page":"3421","article-title":"The mucopolysaccharidoses","author":"Neufeld","year":"2001"},{"key":"10.1038\/sj.mt.6300201_bib2","doi-asserted-by":"crossref","first-page":"6570","DOI":"10.1016\/S0021-9258(19)50465-3","article-title":"Cloning and characterization of cDNA encoding canine alpha-l-iduronidase. mRNA deficiency in mucopolysaccharidosis I dog","volume":"267","author":"Stoltzfus","year":"1992","journal-title":"J Biol Chem"},{"key":"10.1038\/sj.mt.6300201_bib3","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/S0888-7543(05)80182-X","article-title":"Architecture of the canine IDUA gene and mutation underlying canine mucopolysaccharidosis I","volume":"14","author":"Menon","year":"1992","journal-title":"Genomics"},{"key":"10.1038\/sj.mt.6300201_bib4","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1302\/0301-620X.76B6.7983131","article-title":"Bone-marrow transplantation in Hurler's syndrome. Effect on skeletal development","volume":"76","author":"Field","year":"1994","journal-title":"J Bone Joint Surg Br"},{"key":"10.1038\/sj.mt.6300201_bib5","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0022-3476(98)70201-X","article-title":"Follow-up of nine patients with Hurler syndrome after bone marrow transplantation","volume":"133","author":"Guffon","year":"1998","journal-title":"J Pediatr"},{"key":"10.1038\/sj.mt.6300201_bib6","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1182\/blood.V91.7.2601","article-title":"Hurler syndrome: II. outcome of HLA-genotypically identical sibling and HLA-haploidentical related donor bone marrow transplantation in fifty-four children. The storage disease collaborative study group","volume":"91","author":"Peters","year":"1998","journal-title":"Blood"},{"key":"10.1038\/sj.mt.6300201_bib7","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/S0002-9149(03)00909-3","article-title":"Usefulness of bone marrow transplantation in the Hurler syndrome","volume":"92","author":"Braunlin","year":"2003","journal-title":"Am J Cardiol"},{"key":"10.1038\/sj.mt.6300201_bib8","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1056\/NEJMoa032613","article-title":"Cord-blood transplants from unrelated donors in patients with Hurler's syndrome","volume":"350","author":"Staba","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1038\/sj.mt.6300201_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.survophthal.2005.11.007","article-title":"Mucopolysaccharidoses and the eye","volume":"51","author":"Ashworth","year":"2006","journal-title":"Surv Ophthalmol"},{"key":"10.1038\/sj.mt.6300201_bib10","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1056\/NEJM200101183440304","article-title":"Enzyme-replacement therapy in mucopolysaccharidosis I","volume":"344","author":"Kakkis","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1038\/sj.mt.6300201_bib11","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.ymgme.2006.08.007","article-title":"A follow-up study of MPS I patients treated with laronidase enzyme replacement therapy for 6 years","volume":"90","author":"Sifuentes","year":"2007","journal-title":"Mol Genet Metab"},{"key":"10.1038\/sj.mt.6300201_bib12","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1517\/14656566.6.3.489","article-title":"The first 5 years of clinical experience with laronidase enzyme replacement therapy for mucopolysaccharidosis I","volume":"6","author":"Wraith","year":"2005","journal-title":"Expert Opin Pharmacother"},{"key":"10.1038\/sj.mt.6300201_bib13","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.amjcard.2006.02.047","article-title":"Cardiac findings after enzyme replacement therapy for mucopolysaccharidosis type I","volume":"98","author":"Braunlin","year":"2006","journal-title":"Am J Cardiol"},{"key":"10.1038\/sj.mt.6300201_bib14","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.ymthe.2004.08.027","article-title":"Liver-directed neonatal gene therapy prevents cardiac, bone, ear, and eye disease in mucopolysaccharidosis I mice","volume":"11","author":"Liu","year":"2005","journal-title":"Mol Ther"},{"key":"10.1038\/sj.mt.6300201_bib15","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ymgme.2006.08.001","article-title":"Effect of neonatal administration of a retroviral vector expressing alpha-l-iduronidase upon lysosomal storage in brain and other organs in mucopolysaccharidosis I mice","volume":"90","author":"Chung","year":"2007","journal-title":"Mol Genet Metab"},{"key":"10.1038\/sj.mt.6300201_bib16","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.ymthe.2004.10.006","article-title":"Neonatal gene therapy of MPS I mice by intravenous injection of a lentiviral vector","volume":"11","author":"Kobayashi","year":"2005","journal-title":"Mol Ther"},{"key":"10.1038\/sj.mt.6300201_bib17","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/j.ymthe.2004.03.011","article-title":"Correction of metabolic, craniofacial, and neurologic abnormalities in MPS I mice treated at birth with adeno-associated virus vector transducing the human alpha-l-iduronidase gene","volume":"9","author":"Hartung","year":"2004","journal-title":"Mol Ther"},{"key":"10.1038\/sj.mt.6300201_bib18","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1089\/hum.1996.7.13-1595","article-title":"Myoblast gene therapy in canine mucopolysaccharidosis. I: abrogation by an immune response to alpha-l-iduronidase","volume":"7","author":"Shull","year":"1996","journal-title":"Hum Gene Ther"},{"key":"10.1038\/sj.mt.6300201_bib19","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1182\/blood.V88.1.377b.377b","article-title":"Humoral immune response limits gene therapy in canine MPS I","volume":"88","author":"Shull","year":"1996","journal-title":"Blood"},{"key":"10.1038\/sj.mt.6300201_bib20","first-page":"1895","article-title":"Genetically corrected autologous stem cells engraft, but host immune responses limit their utility in canine alpha-l-iduronidase deficiency","volume":"93","author":"Lutzko","year":"1999","journal-title":"Blood"},{"key":"10.1038\/sj.mt.6300201_bib21","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1089\/10430349950017851","article-title":"Gene therapy for canine alpha-l-iduronidase deficiency: in utero adoptive transfer of genetically corrected hematopoietic progenitors results in engraftment but not amelioration of disease","volume":"10","author":"Lutzko","year":"1999","journal-title":"Hum Gene Ther"},{"key":"10.1038\/sj.mt.6300201_bib22","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1089\/104303402760372918","article-title":"In utero injection of alpha-l-iduronidase-carrying retrovirus in canine mucopolysaccharidosis type I: infection of multiple tissues and neonatal gene expression","volume":"13","author":"Meertens","year":"2002","journal-title":"Hum Gene Ther"},{"key":"10.1038\/sj.mt.6300201_bib23","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.ymthe.2006.03.015","article-title":"Mucopolysaccharidosis I cats mount a cytotoxic T lymphocyte response after neonatal gene therapy that can be blocked with CTLA4-Ig","volume":"14","author":"Ponder","year":"2006","journal-title":"Mol Ther"},{"key":"10.1038\/sj.mt.6300201_bib24","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ymgme.2005.08.014","article-title":"Expression in blood cells may contribute to biochemical and pathological improvements after neonatal intravenous gene therapy for mucopolysaccharidosis VII in dogs","volume":"87","author":"Wang","year":"2006","journal-title":"Mol Genet Metab"},{"key":"10.1038\/sj.mt.6300201_bib25","first-page":"244","article-title":"Canine alpha-l-iduronidase deficiency. A model of mucopolysaccharidosis I","volume":"109","author":"Shull","year":"1982","journal-title":"Am J Pathol"},{"key":"10.1038\/sj.mt.6300201_bib26","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1006\/mthe.2002.0809","article-title":"Evaluation of pathological manifestations of disease in mucopolysaccharidosis VII mice after neonatal hepatic gene therapy","volume":"6","author":"Xu","year":"2002","journal-title":"Mol Ther"},{"key":"10.1038\/sj.mt.6300201_bib27","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.ymgme.2004.07.003","article-title":"Intrathecal enzyme replacement therapy reduces lysosomal storage in the brain and meninges of the canine model of MPS I","volume":"83","author":"Kakkis","year":"2004","journal-title":"Mol Genet Metab"},{"key":"10.1038\/sj.mt.6300201_bib28","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S1096-7192(02)00200-7","article-title":"Identification and characterization of 13 new mutations in mucopolysaccharidosis type I patients","volume":"78","author":"Matte","year":"2003","journal-title":"Mol Genet Metab"},{"key":"10.1038\/sj.mt.6300201_bib29","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1006\/bmme.1996.0044","article-title":"Long-term and high-dose trials of enzyme replacement therapy in the canine model of mucopolysaccharidosis I","volume":"58","author":"Kakkis","year":"1996","journal-title":"Biochem Mol Med"},{"key":"10.1038\/sj.mt.6300201_bib30","doi-asserted-by":"crossref","first-page":"12937","DOI":"10.1073\/pnas.91.26.12937","article-title":"Enzyme replacement in a canine model of Hurler syndrome","volume":"91","author":"Shull","year":"1994","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/sj.mt.6300201_bib31","article-title":"Immune response after neonatal transfer of a human factor IX-expressing retroviral vector in dogs, cats, and mice","author":"Xu","year":"2006","journal-title":"Thromb Res"},{"key":"10.1038\/sj.mt.6300201_bib32","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/0002-9149(76)90468-9","article-title":"The heart in the Hurler syndrome: gross, histologic and ultrastructural observations in five necropsy cases","volume":"38","author":"Renteria","year":"1976","journal-title":"Am J Cardiol"},{"key":"10.1038\/sj.mt.6300201_bib33","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.ymgme.2005.05.003","article-title":"Cardiac manifestations in the mouse model of mucopolysaccharidosis I","volume":"86","author":"Jordan","year":"2005","journal-title":"Mol Genet Metab"},{"key":"10.1038\/sj.mt.6300201_bib34","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1203\/01.pdr.0000190579.24054.39","article-title":"Cardiac functional and histopathologic findings in humans and mice with mucopolysaccharidosis type I: implications for assessment of therapeutic interventions in Hurler syndrome","volume":"59","author":"Braunlin","year":"2006","journal-title":"Pediatr Res"},{"key":"10.1038\/sj.mt.6300201_bib35","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1006\/mthe.2002.0527","article-title":"Transduction of hepatocytes after neonatal delivery of a Moloney murine leukemia virus based retroviral vector results in long-term expression of beta-glucuronidase in mucopolysaccharidosis VII dogs","volume":"5","author":"Xu","year":"2002","journal-title":"Mol Ther"},{"key":"10.1038\/sj.mt.6300201_bib36","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1089\/hum.2006.17.253","article-title":"Mutagenesis and oncogenesis by chromosomal insertion of gene transfer vectors","volume":"17","author":"Baum","year":"2006","journal-title":"Hum Gene Ther"},{"key":"10.1038\/sj.mt.6300201_bib37","doi-asserted-by":"crossref","first-page":"14777","DOI":"10.1073\/pnas.0506892102","article-title":"Overcoming the blood-brain barrier with high-dose enzyme replacement therapy in murine mucopolysaccharidosis VII","volume":"102","author":"Vogler","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/sj.mt.6300201_bib38","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1038\/sj.mt.6300112","article-title":"Improvements in mucopolysaccharidosis I mice after adult retroviral vector-mediated gene therapy with immunomodulation","volume":"15","author":"Ma","year":"2007","journal-title":"Mol Ther"},{"key":"10.1038\/sj.mt.6300201_bib39","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1002\/ana.20870","article-title":"Gene therapy of the brain in the dog model of Hurler's syndrome","volume":"60","author":"Ciron","year":"2006","journal-title":"Ann Neurol"},{"key":"10.1038\/sj.mt.6300201_bib40","doi-asserted-by":"crossref","first-page":"13102","DOI":"10.1073\/pnas.192353499","article-title":"Therapeutic neonatal hepatic gene therapy in mucopolysaccharidosis VII dogs","volume":"99","author":"Ponder","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/sj.mt.6300201_bib41","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.ymgme.2004.01.015","article-title":"Neonatal retroviral vector-mediated hepatic gene therapy reduces bone, joint, and cartilage disease in mucopolysaccharidosis VII mice and dogs","volume":"82","author":"Mango","year":"2004","journal-title":"Mol Genet Metab"},{"key":"10.1038\/sj.mt.6300201_bib42","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1161\/01.CIR.0000138747.82487.4B","article-title":"Gene therapy ameliorates cardiovascular disease in dogs with mucopolysaccharidosis VII","volume":"110","author":"Sleeper","year":"2004","journal-title":"Circulation"},{"key":"10.1038\/sj.mt.6300201_bib43","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.ymgme.2006.02.013","article-title":"Newborn screening for lysosomal storage disorders","volume":"88","author":"Meikle","year":"2006","journal-title":"Mol Genet Metab"},{"key":"10.1038\/sj.mt.6300201_bib44","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1373\/clinchem.2004.047167","article-title":"Tandem mass spectrometric analysis of dried blood spots for screening of mucopolysaccharidosis I in newborns","volume":"51","author":"Wang","year":"2005","journal-title":"Clin Chem"}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001616324364?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001616324364?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,8,14]],"date-time":"2021-08-14T02:15:37Z","timestamp":1628907337000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001616324364"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,8]]},"references-count":44,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2007,8]]}},"alternative-id":["S1525001616324364"],"URL":"https:\/\/doi.org\/10.1038\/sj.mt.6300201","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2007,8]]}}}